Literature DB >> 25009318

Genetic association of osteopontin (OPN) and its receptor CD44 genes with susceptibility to Chinese gastric cancer patients.

Yue Qiu1, Yuan Hu, Zuo-Yang Zhang, Lei Ye, Fei-Hong Xu, Marion E Schneider, Xue-Ling Ma, Yi-Xin Du, Xian-Bo Zuo, Fu-Sheng Zhou, Gang Chen, Xu-Shi Xie, Yan Zhang, Hong-Zhen Xia, Ji-Feng Wu, Wei-Dong Du.   

Abstract

PURPOSE: (1) To investigate associations between single nucleotide polymorphisms (SNPs) in osteopontin (OPN) and its receptor-cluster of differentiation 44 (CD44) genes and gastric cancer susceptibility. (2) To explore the correlation of OPN and CD44 expression of gastric cancer.
METHODS: We detected 26 SNPs of the genes in gastric cancer patients from the Chinese Han population by Sequenom technique and performed expression of OPN in combination with CD44 in 243 tissues samples of the cases by tissue microarray and immunohistochemistry (IHC).
RESULTS: We found that the minor alleles of OPN rs4754C>T and OPN rs9138C>A remained strongly associated with decreased gastric cancer risk (P = 1.53 × 10(-4), odds ratio (OR) 0.642, 95 % confidence interval (CI) 0.511-0.808 and P = 1.59 × 10(-4), OR 0.642, 95 %CI 0.510-0.809). OPN variant rs1126772A>G and CD44 variant rs353639A>C significantly contributed to elevated risk of gastric cancer (P = 0.042, OR 1.279, 95 % CI 1.008-1.622 and P = 0.047, OR 1.334, 95 % CI 1.003-1.772). Haplotypes of OPN and CD44 variants significantly influenced risk of gastric cancer. Clinical data indicated that rs4754 and rs9138 of OPN were significantly associated with smoking (P = 0.029, OR 0.343, 95 % CI 0.127-0.926 and P = 0.029, OR 0.343, 95 %CI 0.127-0.926) and OPN rs1126772 revealed associations with tumor-node-metastasis (TNM) stage (P = 0.025, OR 1.765, 95 % CI 1.073-2.905) and tumor differentiation (P = 0.031, OR 1.722, 95 % CI 1.049-2.825). OPN expression was observed in 133 of the 243 cases (54.7 %) by IHC and was correlated with serosa invasion (P = 0.013), TNM stage (P = 0.003) and lymph node metastasis (P = 0.002). CD44 expression was found in 92 of the 243 cases (37.9 %) and was associated with tumor size (P = 0.005) and lymph node metastasis (P = 0.023), respectively. The OPN expression displayed a positive association with CD44 (P = 0.01, r s = 0.164).
CONCLUSIONS: We found that the polymorphisms rs4754, rs9138 and rs1126772 of OPN gene and rs353639 of CD44 gene were significantly associated with gastric cancer. Our IHC data indicated that interaction of OPN and CD44 protein would promote progression and metastasis of gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25009318     DOI: 10.1007/s00432-014-1761-9

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  56 in total

1.  Intracellular osteopontin is an integral component of the CD44-ERM complex involved in cell migration.

Authors:  R Zohar; N Suzuki; K Suzuki; P Arora; M Glogauer; C A McCulloch; J Sodek
Journal:  J Cell Physiol       Date:  2000-07       Impact factor: 6.384

2.  Micro-RNA-181a regulates osteopontin-dependent metastatic function in hepatocellular cancer cell lines.

Authors:  Syamal D Bhattacharya; Juline Garrison; Hongtao Guo; Zhiyong Mi; Jovan Markovic; Victoria M Kim; Paul C Kuo
Journal:  Surgery       Date:  2010-06-23       Impact factor: 3.982

3.  The osteopontin-CD44 survival signal involves activation of the phosphatidylinositol 3-kinase/Akt signaling pathway.

Authors:  Y H Lin; H F Yang-Yen
Journal:  J Biol Chem       Date:  2001-10-05       Impact factor: 5.157

4.  Common cancer stem cell gene variants predict colon cancer recurrence.

Authors:  Armin Gerger; Wu Zhang; Dongyun Yang; Pierre Bohanes; Yan Ning; Thomas Winder; Melissa J LaBonte; Peter M Wilson; Leonor Benhaim; David Paez; Rita El-Khoueiry; Anthony El-Khoueiry; Michael Kahn; Heinz-Josef Lenz
Journal:  Clin Cancer Res       Date:  2011-09-14       Impact factor: 12.531

5.  Down-regulation of osteopontin inhibits metastasis of hepatocellular carcinoma cells via a mechanism involving MMP-2 and uPA.

Authors:  Rong-Xin Chen; Yun-Hong Xia; Tong-Chun Xue; Hong Zhang; Sheng-Long Ye
Journal:  Oncol Rep       Date:  2010-12-21       Impact factor: 3.906

Review 6.  Gastric cancer.

Authors:  Vincenzo Catalano; Roberto Labianca; Giordano D Beretta; Gemma Gatta; Filippo de Braud; Eric Van Cutsem
Journal:  Crit Rev Oncol Hematol       Date:  2009-02-20       Impact factor: 6.312

7.  Receptor-ligand interaction between CD44 and osteopontin (Eta-1).

Authors:  G F Weber; S Ashkar; M J Glimcher; H Cantor
Journal:  Science       Date:  1996-01-26       Impact factor: 47.728

8.  Serum concentration of CD44 variant 6 and its relation to prognosis in patients with gastric carcinoma.

Authors:  H Saito; S Tsujitani; K Katano; M Ikeguchi; M Maeta; N Kaibara
Journal:  Cancer       Date:  1998-09-15       Impact factor: 6.860

9.  Immunohistochemical expression of osteopontin in gastric cancer.

Authors:  Motohiro Imano; Takao Satou; Tatsuki Itoh; Kenichi Sakai; Eizaburo Ishimaru; Atsushi Yasuda; Ying-Feng Peng; Masayuki Shinkai; Fumiharu Akai; Takushi Yasuda; Haruhiko Imamoto; Kiyokata Okuno; Hiroyuki Ito; Hitoshi Shiozaki; Harumasa Ohyanagi
Journal:  J Gastrointest Surg       Date:  2009-07-07       Impact factor: 3.452

10.  Synergistic effect of HLA class II loci and cytokine gene polymorphisms on the risk of gastric cancer in Japanese patients with Helicobacter pylori infection.

Authors:  Takashi Ando; Takeshi Ishikawa; Haruki Kato; Norimasa Yoshida; Yuji Naito; Satoshi Kokura; Nobuaki Yagi; Tomohisa Takagi; Osamu Handa; Jo Kitawaki; Naoto Nakamura; Goji Hasegawa; Michiaki Fukui; Eiko Imamoto; Chie Nakamura; Hirokazu Oyamada; Yutaka Isozaki; Naohito Matsumoto; Yasuyuki Nagao; Mika Okita; Yoshihiro Nakajima; Manabu Kurokawa; Masafumi Nukina; Mitsuhiro Ohta; Shigeto Mizuno; Masakazu Ogata; Hiroshi Obayashi; Hyohun Park; Yoshihiro Kitagawa; Koji Nakano; Toshikazu Yoshikawa
Journal:  Int J Cancer       Date:  2009-12-01       Impact factor: 7.396

View more
  15 in total

1.  Role of cancer stem cell marker CD44 in gastric cancer: a meta-analysis.

Authors:  Wei Wang; Li-Ping Dong; Ning Zhang; Cheng-Hai Zhao
Journal:  Int J Clin Exp Med       Date:  2014-12-15

2.  Cluster of Differentiation 44 (CD44) Gene Variants: A Putative Cancer Stem Cell Marker in Risk Prediction of Bladder Cancer in North Indian Population.

Authors:  Archana Verma; Rakesh Kapoor; Rama Devi Mittal
Journal:  Indian J Clin Biochem       Date:  2016-05-21

3.  Overexpression of osteopontin promotes cell proliferation and migration in human nasopharyngeal carcinoma and is associated with poor prognosis.

Authors:  Haimei Qin; Rong Wang; Guijiang Wei; Huaifei Wang; Guogang Pan; Rentong Hu; Yesheng Wei; Renguang Tang; Junli Wang
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-12-06       Impact factor: 2.503

4.  Genetic association between CD44 polymorphisms and chronic hepatitis B virus infection in a Chinese Han population.

Authors:  Fan Li; Qing Shao; Dong Ji; Bing Li; Guofeng Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

5.  Clinicopathological Significance of Osteopontin in Cholangiocarcinoma Cases.

Authors:  Marut Laohaviroj; Yaovalux Chamgramol; Chawalit Pairojkul; Jason Mulvenna; Banchob Sripa
Journal:  Asian Pac J Cancer Prev       Date:  2016

6.  Associations of five polymorphisms in the CD44 gene with cancer susceptibility in Asians.

Authors:  Qichao Qi; Jiwei Wang; Anjing Chen; Bin Huang; Gang Li; Xingang Li; Jian Wang
Journal:  Sci Rep       Date:  2016-12-21       Impact factor: 4.379

7.  Multiple functional SNPs in differentially expressed genes modify risk and survival of non-small cell lung cancer in Chinese female non-smokers.

Authors:  Xue Fang; Zhihua Yin; Xuelian Li; Lingzi Xia; Xiaowei Quan; Yuxia Zhao; Baosen Zhou
Journal:  Oncotarget       Date:  2017-03-21

8.  Quantitative assessment of CD44 genetic variants and cancer susceptibility in Asians: a meta-analysis.

Authors:  Vishal Chandra; Yun-Mi Lee; Usha Gupta; Balraj Mittal; Jong Joo Kim; Rajani Rai
Journal:  Oncotarget       Date:  2016-11-08

Review 9.  Clinicopathological and prognostic significance of cancer stem cell markers CD44 and CD133 in patients with gastric cancer: A comprehensive meta-analysis with 4729 patients involved.

Authors:  Li Lu; Menglin Wu; Longhao Sun; Weidong Li; Weihua Fu; Xuening Zhang; Tong Liu
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

Review 10.  The biology and role of CD44 in cancer progression: therapeutic implications.

Authors:  Chen Chen; Shujie Zhao; Anand Karnad; James W Freeman
Journal:  J Hematol Oncol       Date:  2018-05-10       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.